Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.33% | 43.75 | 0.9% | $1519.99m | |
| JNJ | Johnson & Johnson | -1.52% | 162.24 | 0.7% | $972.90m | |
| ABBV | AbbVie, Inc. | -1.97% | 105.61 | 1.9% | $972.17m | |
| MRK | Merck & Co., Inc. | -0.30% | 71.47 | 0.7% | $794.72m | |
| LLY | Eli Lilly & Co. | -0.47% | 229.01 | 1.1% | $591.74m | |
| BMY | Bristol-Myers Squibb Co. | -1.68% | 60.28 | 1.0% | $542.97m | |
| AZN | AstraZeneca Plc | 4.38% | 58.00 | 1.0% | $272.53m | |
| NVS | Novartis AG | -1.69% | 82.07 | 0.2% | $166.16m | |
| SNY | Sanofi | -1.43% | 47.69 | 0.2% | $135.73m | |
| GSK | GlaxoSmithKline Plc | -0.75% | 38.64 | 0.2% | $121.96m | |
| RPRX | Royalty Pharma Plc | -4.97% | 36.59 | 0.1% | $113.18m | |
| NVO | Novo Nordisk A/S | -2.26% | 99.12 | 0.1% | $106.86m | |
| VTRS | Viatris, Inc. | -2.69% | 13.21 | 0.0% | $106.32m | |
| RGEN | Repligen Corp. | -0.97% | 303.93 | 6.8% | $101.98m | |
| APLS | Apellis Pharmaceuticals, Inc. | -4.01% | 32.84 | 0.0% | $93.05m |
Company Profile
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.